aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Jivana Biotechnology is a preclinical-stage biotechnology company focused on developing gene silencing therapeutics for cancer treatment. The company targets genetically-defined cancers, including liver, breast, pancreatic, ovarian, and thyroid cancers, as well as leukemias and lymphomas. Their mission is to advance innovative cancer therapies to improve patient outcomes.
Jivana Biotechnology has made significant strides in the field of cancer therapeutics, leveraging cutting-edge gene silencing technology. The company's impact is marked by its commitment to addressing unmet medical needs in oncology.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Cancer Therapeutics
Technology
Biotech
Tags
Healthtech
Revenue Type(s)
Enterprise, Small Business
Geographic Exposure
Americas
When was Jivana Biotechnology founded?
Jivana Biotechnology was founded in 2013.
Where is Jivana Biotechnology’s headquarters located?
Jivana Biotechnology’s headquarters is located in Peoria, IL, US.
When was Jivana Biotechnology’s last funding round?
Jivana Biotechnology’s most recent funding round was for $1M (USD) in October 2016.
How many employees does Jivana Biotechnology have?
Jivana Biotechnology has 30 employees as of Feb 5, 2024.
How much has Jivana Biotechnology raised to-date?
As of July 05, 2023, Jivana Biotechnology has raised a total of $1M (USD) since Oct 25, 2016.
Add Comparison
Total Raised to Date
$1M
USD
Last Update Oct 25, 2016
Last Deal Details
$1M
USD
Oct 25, 2016
Series Unknown
Total Employees Over Time
30
As of Feb 2024
Jivana Biotechnology Address
Peoria,
Illinois
61614
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts